Astria Therapeutics Inc News

Astria Therapeutics Analyst Ratings

BenzingaApr 23 18:20

Wedbush Maintains Outperform on Astria Therapeutics, Raises Price Target to $22

BenzingaMar 26 21:34

Astria Therapeutics Analyst Ratings

BenzingaMar 26 00:34

Astria Therapeutics Analyst Ratings

BenzingaMar 14 19:11

Astria Therapeutics Analyst Ratings

BenzingaMar 5 20:02

HC Wainwright & Co. Reiterates Buy on Astria Therapeutics, Maintains $18 Price Target

BenzingaMar 5 20:04

Astria Therapeutics Analyst Ratings

BenzingaJan 31 00:01

Astria Therapeutics Analyst Ratings

BenzingaNov 16, 2023 02:10

Oppenheimer Adjusts Astria Therapeutics Price Target to $25 From $30, Maintains Outperform Rating

MT NewswiresNov 15, 2023 22:12

Wedbush Trims Astria Therapeutics' Price Target to $17 From $18, Keeps Outperform Rating

MT NewswiresNov 14, 2023 01:01

Wedbush Maintains Outperform on Astria Therapeutics, Lowers Price Target to $18

BenzingaOct 13, 2023 23:22

Astria Therapeutics Analyst Ratings

BenzingaOct 13, 2023 23:21

HC Wainwright & Co. Maintains Buy on Astria Therapeutics, Lowers Price Target to $18

BenzingaOct 12, 2023 19:06

Astria Therapeutics Analyst Ratings

BenzingaOct 12, 2023 19:02

Wedbush Trims Astria Therapeutics' Price Target to $25 From $26, Keeps Outperform Rating

MT NewswiresAug 8, 2023 19:09

Astria Therapeutics Analyst Ratings

BenzingaAug 8, 2023 18:30

Evercore ISI Group Initiates Coverage On Astria Therapeutics With Outperform Rating, Announces Price Target of $18

BenzingaMar 28, 2023 19:10

Wedbush Adjusts Price Target on Astria Therapeutics to $26 From $27, Keeps Outperform Rating

MT NewswiresMar 22, 2023 22:57

HC Wainwright & Co. Reiterates Buy on Astria Therapeutics, Maintains $20 Price Target

BenzingaFeb 25, 2023 02:00

Moderna To Rally Over 42%? Here Are 10 Other Price Target Changes For Monday

Benzinga Real-time NewsDec 19, 2022 21:31